The global "Companion Diagnostics Industry ” Forecast to 2030 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The Companion Diagnostics Market report also examines the current state of the industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data.

The global companion diagnostics market size was valued at USD 6.80 billion in 2021 and is projected to grow from USD 7.67 billion in 2022 to USD 15.91 billion by 2029, at a CAGR of 11.0% during the forecast period.

Global Companion Diagnostics Market: Drivers and Restraints:

The report offers insightful data concerning production expenses, supply chain intricacies, and crucial raw materials pertinent to the Companion Diagnostics Market sector. Additionally, it assesses the repercussions of COVID-19 on the industry and offers guidance on adapting to evolving market landscapes. Key market limitations, like economic hurdles in emerging nations and business obstacles, are identified. This understanding empowers businesses to formulate strategies for mitigating risks and overcoming challenges, thereby paving the way for sustained success in this vibrant and dynamic industry.

List of Key Players Covered in the Report:

• Abbott (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Agilent Technologies, Inc. (U.S.)
• Illumina, Inc. (U.S.)
• Guardant Health (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• BIOMERIEUX (France)
• QIAGEN (Germany)
• Myriad Genetics, Inc. (U.S.)

Report includes Competitor's Landscape:

• Major trends and growth projections by region and country
• Key winning strategies followed by the competitors
• Who are the key competitors in this industry?
• What shall be the potential of this industry over the forecast tenure?
• What are the factors propelling the demand?

Research Methodology:

We follow a robust research methodology that involves data triangulation based on top-down, and bottom-up approaches, and validation of the estimated market numbers through primary research. The information used to estimate the Companion Diagnostics Market size and forecast for various segments at the global, regional, and country levels is derived from the most credible published sources and through interviews with the right stakeholders. The Growth rate or CAGR exhibited by a market for a certain forecast period is calculated on the basis of various factors and their level of impact on the market.